Jens Claus Munck Petersen

Title: Jens Claus Munck Petersen: Innovator in Neuropharmacology

Introduction

Jens Claus Munck Petersen is a notable inventor based in Aarhus, Denmark. He has made significant contributions to the field of neuropharmacology, particularly through his innovative work on specific ligands related to the protein Sortilin. His research aims to advance the treatment of various neurological disorders.

Latest Patents

Jens holds a patent for "Specific ligands to sortilin." This invention provides a Sortilin crystal and methods for growing said crystal. The invention also includes methods for designing specific ligands based on the crystal structure of Sortilin. Furthermore, it relates to the preparation and use of such ligands for developing a medicament aimed at treating diseases, damage, or disorders of the central and peripheral nervous systems. He has 1 patent to his name.

Career Highlights

Jens is associated with H. Lundbeck A/S, a prominent pharmaceutical company specializing in brain diseases. His work at Lundbeck has allowed him to focus on innovative solutions for treating neurological conditions, contributing to the company's mission of improving patients' lives.

Collaborations

Throughout his career, Jens has collaborated with esteemed colleagues such as Poul Nissen and Peder Søndergaard Madsen. These partnerships have fostered a collaborative environment that enhances research and development in neuropharmacology.

Conclusion

Jens Claus Munck Petersen is a distinguished inventor whose work on Sortilin ligands has the potential to revolutionize treatments for neurological disorders. His contributions to the field underscore the importance of innovation in medicine.